Investing.com - Armata Pharma reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Armata Pharma announced earnings per share of $-0.240 on revenue of $1.34M. Analysts polled by Investing.com anticipated EPS of $-0.195 on revenue of $1.13M.
Armata Pharma shares are up 86.39% from the beginning of the year, still down 49.46% from its 52 week high of $6.49 set on November 24, 2021.
Armata Pharma follows other major Healthcare sector earnings this month
Armata Pharma's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar